Premium
Adverum Biotechnologies Inc (ADVM)
NASDAQ
Hot Features
Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
Adverum Biotechnologies Inc is a U.S.-based clinical-stage gene therapy company. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. The company primarily generates revenue through license research and collaborat... Adverum Biotechnologies Inc is a U.S.-based clinical-stage gene therapy company. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. The company primarily generates revenue through license research and collaboration arrangements with its strategic partners. Its lead product candidate is ADVM-022 which is a single in-office intravitreal IVT injection gene therapy designed to deliver long-term durable levels of aflibercept associated with a robust sustained treatment response reducing the treatment burden and fluctuations in macular fluid associated with frequent anti-vascular endothelial growth factor VEGF injections. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.08 | 1.96078431373 | 4.08 | 5.14 | 3.52 | 380898 | 4.29412983 | CS |
| 4 | -0.24 | -5.45454545455 | 4.4 | 5.14 | 3.52 | 205960 | 4.2253887 | CS |
| 12 | -1.68 | -28.7671232877 | 5.84 | 6.07 | 3.52 | 200920 | 4.60170517 | CS |
| 26 | -2.57 | -38.1872213967 | 6.73 | 8.56 | 3.52 | 206782 | 5.97491863 | CS |
| 52 | -15.74 | -79.0954773869 | 19.9 | 20.9 | 3.52 | 368389 | 10.77254469 | CS |
| 156 | -8.24 | -66.4516129032 | 12.4 | 29.8 | 3.52 | 650341 | 12.86571323 | CS |
| 260 | -125.34 | -96.7876447876 | 129.5 | 269.8 | 3.52 | 1023044 | 50.29185352 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
